A Single CD4 Test with 250 Cells/Mm³ Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria

• Charles F. Gilks ,

  Contributed equally to this work with: Charles F. Gilks, A. Sarah Walker

  Affiliation Department of Medicine, Imperial College, London, United Kingdom

  ⨯
• A. Sarah Walker ,

  Contributed equally to this work with: Charles F. Gilks, A. Sarah Walker

  * E-mail: asw@ctu.mrc.ac.uk

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Paula Munderi,

  Affiliation Medical Research Council/ Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda

  ⨯
• Cissy Kityo,

  Affiliation Joint Clinical Research Centre, Kampala, Uganda

  ⨯
• Andrew Reid,

  Affiliation Clinical Research Centre, University of Zimbabwe, Harare, Zimbabwe

  ⨯
• Elly Katabira,

  Affiliation Infectious Diseases Institute, Mulago, Uganda

  ⨯
• Ruth L. Goodall,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Heiner Grosskurth,

  Affiliation Medical Research Council/ Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda

  ⨯
• Peter Mugyenyi,

  Affiliation Joint Clinical Research Centre, Kampala, Uganda

  ⨯
• James Hakim,

  Affiliation Clinical Research Centre, University of Zimbabwe, Harare, Zimbabwe

  ⨯
• Diana M. Gibb,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• on behalf of the DART Virology Group and Trial Team